- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/80 - AcidsEsters in position 3
Patent holdings for IPC class C07D 213/80
Total number of patents in this class: 522
10-year publication summary
|
30
|
41
|
41
|
40
|
30
|
31
|
37
|
29
|
23
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Crop Protection AG | 6077 |
12 |
| Shionogi & Co., Ltd. | 850 |
12 |
| Xwpharma Ltd. | 58 |
11 |
| Bristol-myers Squibb Company | 4872 |
9 |
| The General Hospital Corporation | 4751 |
8 |
| ViiV Healthcare Company | 154 |
8 |
| The Trustees of Columbia University in the City of New York | 3580 |
7 |
| Almirall, S.A. | 494 |
7 |
| Astellas Pharma Inc. | 1083 |
7 |
| Boehringer Ingelheim International GmbH | 4645 |
6 |
| Agro-kanesho Co., Ltd. | 48 |
6 |
| Laurus Labs Limited | 100 |
6 |
| Theravance Biopharma R&D IP, LLC | 456 |
6 |
| Oxular Acquisitions Limited | 21 |
6 |
| President and Fellows of Harvard College | 5993 |
5 |
| Vertex Pharmaceuticals Incorporated | 1608 |
5 |
| Global Blood Therapeutics, Inc. | 183 |
5 |
| Imbria Pharmaceuticals, Inc. | 65 |
5 |
| Zevra Therapeutics, Inc. | 99 |
5 |
| BASF SE | 20967 |
4 |
| Other owners | 382 |